About Us
Company Overview
Our Leadership
Global Supply Chain
IP Protection
Quality & Compliance
Environmental, Health and Safety
Solutions and Services
Discovery Synthesis
GMP Services
Generic APIs
FTE Services
Regulatory Affairs
Peptide Synthesis
Oligonucleotide Synthesis
Cosmetic Peptides
GMP Manufacturing
GMP Production Capacity
GMP Compliance & Certification
Leuprorelin Acetate
Triptorelin Acetate
Triptorelin Pamoate
Goserelin Acetate
Lanreotide
Cetrorelix Acetate
Ganirelix Acetate
Exenatide Acetate
Semaglutide
Terlipressin Acetate
Teduglutide
Linaclotide
Plecanatide
Difelikefalin
Resources Center
FAQ
White Paper
Video
News
Company News
Blog
Careers
Contact Us
Catalog Peptides
US Operation
WHAT ARE YOU LOOKING FOR?
Home
About Us
About Us
Company Overview
Our Leadership
Global Supply Chain
IP Protection
Quality & Compliance
Environmental, Health and Safety
Solutions and Services
Solutions and Services
Discovery Synthesis
GMP Services
Generic APIs
FTE Services
Regulatory Affairs
Resources Center
Resources Center
FAQ
White Paper
Video
News
News
Company News
Blog
Careers
Contact Us
Catalog Peptides
US Operation
Email Us
Search
Search
Home
Catalog Peptides
Defensins
Defensins
DEFS-001A
Defensin (human) HNP-2
Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Cys1&Cys29 bridge,Cys3&Cys18 bridge Cys8&Cys28 bridge)
DEFS-001B
Defensin (human) HNP-2
Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Cys1&Cys29 bridge , Cys3&Cys18 bridge Cys8&Cys28 bridge)
DEFS-002A
Defensin-1 (human) HNP-1
Ala-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Cys2&Cys30 bridge , Cys4&Cys19 bridge , Cys 9&Cys29 bridge)
DEFS-002B
Defensin-1 (human) HNP-1
Ala-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Cys2&Cys30 bridge , Cys4&Cys19 bridge , Cys 9&Cys29 bridge)
DEFS-003A
b-Defensin-1, human
Asp-His-Tyr-Asn-Cys-Val-Ser-Ser-Gly-Gly-Gln-Cys-Leu-Tyr-Ser-Ala-Cys-Pro-Ile-Phe-Thr-Lys-Ile-Gln-Gly-Thr-Cys-Tyr-Arg-Gly-Lys-Ala-Lys-Cys-Cys-Lys(Cys5&Cys34 bridge , Cys12&Cys27 bridge , Cys17&Cys35 bridge)
DEFS-003B
b-Defensin-1, human
Asp-His-Tyr-Asn-Cys-Val-Ser-Ser-Gly-Gly-Gln-Cys-Leu-Tyr-Ser-Ala-Cys-Pro-Ile-Phe-Thr-Lys-Ile-Gln-Gly-Thr-Cys-Tyr-Arg-Gly-Lys-Ala-Lys-Cys-Cys-Lys(Cys5&Cys34 bridge , Cys12&Cys27 bridge , Cys17&Cys35 bridge)
DEFS-004A
b-Defensin-2, human
Gly-Ile-Gly-Asp-Pro-Val-Thr-Cys-Leu-Lys-Ser-Gly-Ala-Ile-Cys-His-Pro-Val-Phe-Cys-Pro-Arg-Arg-Tyr-Lys-Gln-Ile-Gly-Thr-Cys-Gly-Leu-Pro-Gly-Thr-Lys-Cys-Cys-Lys-Lys-Pro(Cys8&Cys37 bridge , Cys20&Cys38 bridge , Cys15&Cys30 bridge)
DEFS-004B
b-Defensin-2, human
Gly-Ile-Gly-Asp-Pro-Val-Thr-Cys-Leu-Lys-Ser-Gly-Ala-Ile-Cys-His-Pro-Val-Phe-Cys-Pro-Arg-Arg-Tyr-Lys-Gln-Ile-Gly-Thr-Cys-Gly-Leu-Pro-Gly-Thr-Lys-Cys-Cys-Lys-Lys-Pro(Cys8&Cys37 bridge , Cys20&Cys38 bridge , Cys15&Cys30 bridge)
DEFS-005A
b-Defensin-3, human
Gly-Ile-Ile-Asn-Thr-Leu-Gln-Lys-Tyr-Tyr-Cys-Arg-Val-Arg-Gly-Gly-Arg-Cys-Ala-Val-Leu-Ser-Cys-Leu-Pro-Lys-Glu-Glu-Gln-Ile-Gly-Lys-Cys-Ser-Thr-Arg-Gly-Arg-Lys-Cys-Cys-Arg-Arg-Lys-Lys(Cys11&Cys40 bridge , Cys18&Cys33 bridge , Cys23&Cys41 bridge)
DEFS-005B
b-Defensin-3, human
Gly-Ile-Ile-Asn-Thr-Leu-Gln-Lys-Tyr-Tyr-Cys-Arg-Val-Arg-Gly-Gly-Arg-Cys-Ala-Val-Leu-Ser-Cys-Leu-Pro-Lys-Glu-Glu-Gln-Ile-Gly-Lys-Cys-Ser-Thr-Arg-Gly-Arg-Lys-Cys-Cys-Arg-Arg-Lys-Lys(Cys11&Cys40 bridge , Cys18&Cys33 bridge , Cys23&Cys41 bridge)
DEFS-006A
b-Defensin-4, human
Glu-Leu-Asp-Arg-Ile-Cys-Gly-Tyr-Gly-Thr-Ala-Arg-Cys-Arg-Lys-Lys-Cys-Arg-Ser-Gln-Glu-Tyr-Arg-Ile-Gly-Arg-Cys-Pro-Asn-Thr-Tyr-Ala-Cys-Cys-Leu-Arg-Lys(Cys6&Cys33 bridge , Cys13&Cys27 bridge Cys17&34 bridge)
DEFS-006B
b-Defensin-4, human
Glu-Leu-Asp-Arg-Ile-Cys-Gly-Tyr-Gly-Thr-Ala-Arg-Cys-Arg-Lys-Lys-Cys-Arg-Ser-Gln-Glu-Tyr-Arg-Ile-Gly-Arg-Cys-Pro-Asn-Thr-Tyr-Ala-Cys-Cys-Leu-Arg-Lys(Cys6&Cys33 bridge , Cys13&Cys27 bridge Cys17&34 bridge)
DEFS-007A
Defensin HNP-3 (human)
Asp-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Cys2 and Cys30/Cys4 and Cys19/Cys9 and Cys29 Bridge)
DEFS-007B
Defensin HNP-3 (human)
Asp-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Cys2 and Cys30/Cys4 and Cys19/Cys9 and Cys29 Bridge)
DEFS-007C
Defensin HNP-3 (human)
Asp-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Cys2 and Cys30/Cys4 and Cys19/Cys9 and Cys29 Bridge)
DEFS-008A
alpha-Defensin 6
Ala-Phe-Thr-Cys-His-Cys-Arg-Arg-Ser-Cys-Tyr-Ser-Thr-Glu-Tyr-Ser-Tyr-Gly-Thr-Cys-Thr-Val-Met-Gly-Ile-Asn-His-Arg-Phe-Cys-Cys-Leu(Cys4 and Cys31/Cys6 and Cys20/Cys10 and Cys30 Bridge)
DEFS-008B
alpha-Defensin 6
Ala-Phe-Thr-Cys-His-Cys-Arg-Arg-Ser-Cys-Tyr-Ser-Thr-Glu-Tyr-Ser-Tyr-Gly-Thr-Cys-Thr-Val-Met-Gly-Ile-Asn-His-Arg-Phe-Cys-Cys-Leu(Cys4 and Cys31/Cys6 and Cys20/Cys10 and Cys30 Bridge)
DEFS-008C
alpha-Defensin 6
Ala-Phe-Thr-Cys-His-Cys-Arg-Arg-Ser-Cys-Tyr-Ser-Thr-Glu-Tyr-Ser-Tyr-Gly-Thr-Cys-Thr-Val-Met-Gly-Ile-Asn-His-Arg-Phe-Cys-Cys-Leu(Cys4 and Cys31/Cys6 and Cys20/Cys10 and Cys30 Bridge)
Chinese Peptide Updates
25
Sep
2023
The Hidden Language of Glycosylated Peptides: A Key to Health and Disease
Custom Oligonucleotide Synthesis: Unraveling the Power of Precision
Sep 11, 2023
Exhibition Review | CPHI China 2023
Jun 25, 2023
Exhibition Review | Chinese Peptide Company Biochemistry Attended the 17th China International Peptide Conference
Jun 20, 2023
86-571-86737011
Your browser does not support VBScript!
